Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Arico-Muendel, C.C.
Right arrow Articles by Wolfson, A.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arico-Muendel, C.C.
Right arrow Articles by Wolfson, A.J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Protein Engineering, Vol. 12, No. 3, 189-202, March 1999
© 1999 Oxford University Press

Solution structure and dynamics of a serpin reactive site loop using interleukin 1ß as a presentation scaffold

C.C. Arico-Muendel1, A. Patera2, T.C. Pochapsky3, M. Kuti and A.J. Wolfson4

Department of Chemistry, Brandeis University, Waltham, MA 02454-9110 and 4 Department of Chemistry, Wellesley College, Wellesley, MA 02181-8284, USA

Human interleukin-1ß (IL1ß) was used as a presentation scaffold for the characterization of the reactive site loop (RSL) of the serpin {alpha}1-antitrypsin (A1AT), the physiological inhibitor of leukocyte elastase. A chimeric protein was generated by replacement of residues 50–53 of IL1ß, corresponding to an exposed reverse turn in IL1ß, with the 10-residue P5-P5' sequence EAIPMSIPPE from A1AT. The chimera (antitrypsin-interleukin, AT-IL) inhibits elastase specifically and also binds the IL1ß receptor. Multinuclear NMR characterization of AT-IL established that, with the exception of the inserted sequence, the structure of the IL1ß scaffold is preserved in the chimera. The structure of the inserted RSL was analyzed relative to that of the isolated 10-residue RSL peptide, which was shown to be essentially disordered in solution. The chimeric RSL was also found to be solvent exposed and conformationally mobile in comparison with the IL1ß scaffold, and there was no evidence of persisting interactions with the scaffold outside of the N- and C-terminal linkages. However, AT-IL exhibits sigificant differences in chemical shift and NOE patterns relative to the isolated RSL that are consistent with local features of non-random structure. The proximity of these features to the P1-P1' residues suggests that they may be responsible for the inhibitory activity of the chimera.

Keywords: serpin/{alpha}1-antitrypsin/interleukin-1ß/protease inhibitors

1 Present address: Department of Chemistry, PRAECIS Pharmaceuticals, Inc., 1 Hampshire Street, Cambridge, MA 02139, USA

2 Present address: Department of Chemistry and Biochemistry, Northwestern University, Evanston IL 60208-3113, USA

3 To whom correspondence should be addressed


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Gosavi, P. C. Whitford, P. A. Jennings, and J. N. Onuchic
Extracting function from a {beta}-trefoil folding motif
PNAS, July 29, 2008; 105(30): 10384 - 10389.
[Abstract] [Full Text] [PDF]


Home page
Protein Eng Des SelHome page
Z. Mucsi, Z. Gaspari, G. Orosz, and A. Perczel
Structure-oriented rational design of chymotrypsin inhibitor models
Protein Eng. Des. Sel., September 1, 2003; 16(9): 673 - 681.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.